VanEck Biotech ETF

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BBH and other ETFs, options, and stocks.

About BBH

BBH tracks a market-cap-weighted index of the 25 largest biotech firms globally. 

Index-Tracked
MSCI ACWI NR USD
Index-TrackedMSCI ACWI NR USD
Category
Health
CategoryHealth
Number of holdings
26
Number of holdings26
Inception Date
Dec 20, 2011
Inception DateDec 20, 2011

BBH Key Statistics

AUM
376.61M
AUM376.61M
Price-Earnings ratio
35.70
Price-Earnings ratio35.70
30-Day yield
0.43
30-Day yield0.43
Average volume
9.96K
Average volume9.96K
High today
$191.37
High today$191.37
Low today
$190.63
Low today$190.63
Open price
$190.63
Open price$190.63
Volume
3.69K
Volume3.69K
52 Week high
$200.00
52 Week high$200.00
52 Week low
$135.34
52 Week low$135.34
Expense ratio
0.35
Expense ratio0.35

Stock Snapshot

The current VanEck Biotech ETF(BBH) stock price is $190.88, with a market capitalization of 377.29M. The stock trades at a price-to-earnings (P/E) ratio of 35.70 and offers a dividend yield of 83.1%.

During the trading session on 2026-01-16, VanEck Biotech ETF(BBH) shares reached a daily high of $191.37 and a low of $190.63. At a current price of $190.88, the stock is +0.1% higher than the low and still -0.3% under the high.

Trading activity shows a volume of 3.69K, compared to an average daily volume of 9.96K.

Over the past 52 weeks, VanEck Biotech ETF(BBH) stock has traded between a high of $200.00 and a low of $135.34.

Over the past 52 weeks, VanEck Biotech ETF(BBH) stock has traded between a high of $200.00 and a low of $135.34.

Average Annual Return

All investments involve risks, including the loss of principal. Performance data represents past performance and is no guarantee of future results. Investment returns and principal value will fluctuate and are subject to market volatility. An investment, when redeemed, may be worth more or less than the original cost. Current performance may be lower or higher than the performance data quoted. Options are risky and aren’t suitable for all investors. To learn more about risks, read the .